PL3456334T3 - Bakterie kwasu mlekowego do stosowania dla zapobiegania ubytkowi masy kostnej u ssaków - Google Patents

Bakterie kwasu mlekowego do stosowania dla zapobiegania ubytkowi masy kostnej u ssaków

Info

Publication number
PL3456334T3
PL3456334T3 PL18202594T PL18202594T PL3456334T3 PL 3456334 T3 PL3456334 T3 PL 3456334T3 PL 18202594 T PL18202594 T PL 18202594T PL 18202594 T PL18202594 T PL 18202594T PL 3456334 T3 PL3456334 T3 PL 3456334T3
Authority
PL
Poland
Prior art keywords
mammals
lactic acid
acid bacteria
bone loss
preventing bone
Prior art date
Application number
PL18202594T
Other languages
English (en)
Inventor
Robert Allen Britton
Laura Rae MCCABE
Eamonn Connolly
Original Assignee
Biogaia Ab
Michigan State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab, Michigan State University filed Critical Biogaia Ab
Publication of PL3456334T3 publication Critical patent/PL3456334T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL18202594T 2012-06-04 2013-06-04 Bakterie kwasu mlekowego do stosowania dla zapobiegania ubytkowi masy kostnej u ssaków PL3456334T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261689338P 2012-06-04 2012-06-04
EP13800449.4A EP2854826B9 (en) 2012-06-04 2013-06-04 Lactobacillus reuteri atcc pta 6475 for use in prevention or treatment of bone loss in mammals
EP18202594.0A EP3456334B1 (en) 2012-06-04 2013-06-04 Lactic acid bacteria for use in preventing bone loss in mammals
PCT/SE2013/050646 WO2013184064A1 (en) 2012-06-04 2013-06-04 Selection and use of lactic acid bacteria preventing bone loss in mammals

Publications (1)

Publication Number Publication Date
PL3456334T3 true PL3456334T3 (pl) 2021-05-04

Family

ID=49712339

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13800449T PL2854826T3 (pl) 2012-06-04 2013-06-04 Lactobacillus reuteri atcc pta 6475 do stosowania dla zapobiegania utracie kości u ssaków
PL18202594T PL3456334T3 (pl) 2012-06-04 2013-06-04 Bakterie kwasu mlekowego do stosowania dla zapobiegania ubytkowi masy kostnej u ssaków

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13800449T PL2854826T3 (pl) 2012-06-04 2013-06-04 Lactobacillus reuteri atcc pta 6475 do stosowania dla zapobiegania utracie kości u ssaków

Country Status (16)

Country Link
US (4) US20150150917A1 (pl)
EP (2) EP3456334B1 (pl)
JP (1) JP6193981B2 (pl)
KR (2) KR102191537B1 (pl)
CN (1) CN104755091B (pl)
AU (2) AU2013272330B2 (pl)
CA (1) CA2875841C (pl)
DK (2) DK3456334T3 (pl)
ES (2) ES2847424T3 (pl)
HR (1) HRP20190162T1 (pl)
HU (1) HUE042643T2 (pl)
LT (1) LT2854826T (pl)
PL (2) PL2854826T3 (pl)
SI (1) SI2854826T1 (pl)
TR (1) TR201901771T4 (pl)
WO (1) WO2013184064A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101915904B1 (ko) 2016-08-12 2018-11-06 한국식품연구원 락토바실러스 인테스티날리스를 포함하는 갱년기 예방 또는 치료용 조성물
KR102120479B1 (ko) * 2018-10-30 2020-06-09 주식회사 종근당바이오 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
CA3127898A1 (en) * 2019-02-05 2020-08-13 Elanco Us Inc. A genetically modified lactobacillus and uses thereof
KR102080498B1 (ko) * 2019-08-23 2020-02-24 정영옥 페룰산 및 유산균을 유효성분으로 포함하는 골감소증 개선 또는 예방용 식품 조성물
WO2021112041A1 (ja) * 2019-12-02 2021-06-10 雪印メグミルク株式会社 骨強化剤
CN111718903A (zh) * 2020-06-24 2020-09-29 江南大学 一种筛选可预防和/或治疗骨质疏松的药物的方法
CN114711429B (zh) * 2021-06-08 2023-11-17 青岛蔚蓝生物股份有限公司 一株具有增强骨健康作用的罗伊氏乳杆菌及其应用
CN114634901B (zh) * 2022-05-18 2022-08-30 微康益生菌(苏州)股份有限公司 一种促进骨骼健康的干酪乳杆菌lc16及其培养方法与应用
KR102937770B1 (ko) * 2023-08-09 2026-03-12 국립한국교통대학교산학협력단 골다공증 억제 균주 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005537236A (ja) * 2002-06-13 2005-12-08 ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク プロバイオティック治療
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
CN101233231B (zh) * 2005-07-26 2011-06-29 内斯特克有限公司 抗肥胖剂及抗肥胖食品
US20100047320A1 (en) * 2006-09-07 2010-02-25 Satya Prakash Oral polymeric membrane feruloyl esterase producing bacteria formulation
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis

Also Published As

Publication number Publication date
EP2854826B1 (en) 2018-11-14
CN104755091A (zh) 2015-07-01
US20180200313A1 (en) 2018-07-19
US20170128501A1 (en) 2017-05-11
CN104755091B (zh) 2020-07-21
KR20150028968A (ko) 2015-03-17
KR20200044134A (ko) 2020-04-28
HK1211847A1 (en) 2016-06-03
AU2018200524B2 (en) 2019-07-18
EP2854826B9 (en) 2019-05-08
EP2854826A1 (en) 2015-04-08
HRP20190162T1 (hr) 2019-04-05
US20150150917A1 (en) 2015-06-04
LT2854826T (lt) 2019-02-11
EP3456334A1 (en) 2019-03-20
ES2847424T3 (es) 2021-08-03
CA2875841A1 (en) 2013-12-12
AU2013272330A1 (en) 2015-01-15
AU2018200524A1 (en) 2018-02-15
DK2854826T3 (en) 2019-03-11
HUE042643T2 (hu) 2019-07-29
PL2854826T3 (pl) 2019-06-28
US20190142879A1 (en) 2019-05-16
US9968643B2 (en) 2018-05-15
TR201901771T4 (tr) 2019-03-21
US10232001B2 (en) 2019-03-19
EP2854826A4 (en) 2016-07-06
AU2013272330B2 (en) 2017-11-02
ES2711427T3 (es) 2019-05-03
WO2013184064A1 (en) 2013-12-12
EP3456334B1 (en) 2020-11-11
US10537598B2 (en) 2020-01-21
SI2854826T1 (sl) 2019-03-29
ES2711427T8 (es) 2019-06-20
DK3456334T3 (da) 2021-01-25
KR102191537B1 (ko) 2020-12-16
JP2015526389A (ja) 2015-09-10
CA2875841C (en) 2021-02-02
JP6193981B2 (ja) 2017-09-06

Similar Documents

Publication Publication Date Title
GB201206599D0 (en) Probiotic bacteria
ZA201405100B (en) Lactic acid extraction
GB201117313D0 (en) Bacterium for use in medicine
IL230836A0 (en) Disinfection system with multi-cell dispenser
EP2911598A4 (en) SURGICAL SYSTEM
ZA201308417B (en) Tissue healing
EP2806931A4 (en) MODULAR PULMONARY TREATMENT SYSTEM
EP2796105A4 (en) SURGICAL SYSTEM
EP2696800A4 (en) POLYAXIAL DENTAL IMPLANT SYSTEM
PL2685994T3 (pl) Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie
ZA201706997B (en) Sterilization process
PL2582787T3 (pl) Bakterie kwasu mlekowego do jogurtu
EP2872028A4 (en) MEDICAL SYSTEM
GB201510444D0 (en) Regional medical collaboration system
PL2630265T3 (pl) Szczepy bakterii kwasu mlekowego nadające teksturę
PT2809168T (pt) Bactérias probióticas microencapsuladas em multicamadas
SG11201400196UA (en) Lactic acid bacteria for promoting physical activity
IL230305A (en) Milk-based compound
PT2717859T (pt) Formulação de aripiprazol liofilizada
EP2687181A4 (en) SURGICAL SYSTEM
HUE039650T2 (hu) Rendszer gyógykezeléshez
DK3456334T3 (da) Mælkesyrebakterier til anvendelse i forebyggelse af knogletab hos pattedyr
EP2822627A4 (en) STERILIZATION AND HUMIDIFICATION APPARATUS AND INCUBATOR
GB201109756D0 (en) Bacteria
GB201503568D0 (en) Sterilization system for aquaculture